Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancers|January 26, 2024
Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like CellsYoussef Al Hmada, Robert T Brodell, Naji Kharouf, et al.
Cells|February 9, 2024
CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug ResistanceNaji Kharouf, Thomas W Flanagan, Abdulhadi A Alamodi, et al.
Histology and Histopathology|June 16, 2016
Cancer stem cell as therapeutic target for melanoma treatmentAbdulhadi A Alamodi, Abdulaziz M Eshaq, Sofie-Yasmin Hassan, et al.
Oncogene|July 4, 2020
Melanoma stem cell maintenance and chemo-resistance are mediated by CD133 signal to PI3K-dependent pathwaysSiraj M El Jamal, Abdulhadi Alamodi, Renate U Wahl, et al.
Cancers|August 10, 2024
Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and ResistanceAbdulaziz M Eshaq, Thomas W Flanagan, Sofie-Yasmin Hassan, et al.
Cells|April 27, 2026
Stemness and Survival: CD117<sup>+</sup>/CD133<sup>+</sup> Subpopulations Sustain PI3K Signaling and Drive Imatinib Resistance in Head and Neck Mucosal MelanomaSofie-Yasmin Hassan, Simeon Santourlidis, Thomas W Flanagan, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 18, 2018
MEF2B is a member of the BCL6 gene transcriptional complex and induces its expression in diffuse large B-cell lymphoma of the germinal center B-cell-like typeSiraj M El Jamal, Zakaria Grada, Mohamed H El Dinali, et al.
Pageof 2